Menu

Search
Close this search box.

Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19 and Plans to Seek U.S. Emergency Use Authorization

Risk of symptomatic COVID-19 was reduced by 71% compared to placebo in pre-exposure prophylaxis and 75% compared to placebo in post-exposure prophylaxis Risk of hospitalization or death in participants with mild to moderate COVID-19 was reduced by 66% compared to placebo in the primary efficacy analysis population and by 77% compared

Read More

Umit Ciftci Named Regional Business Development Manager for Turkey

TEMECULA, Calif., March 29, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Umit Ciftci has been named Regional Business Development Manager for Turkey and the surrounding areas. Based

Read More

EDU FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages New Oriental Education & Technology Group Inc. Investors with Losses to Secure Counsel Before Important April 5 Deadline in Securities Class Action – EDU

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of New Oriental Education & Technology Group Inc. (NYSE: EDU) between April 24, 2018 and July 22, 2021, inclusive (the “Class Period”), of the important April 5, 2022 lead plaintiff deadline. SO […]

Read More

TLS FINAL DEADLINE ALERT: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Telos Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action – TLS

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Telos Corporation (NASDAQ: TLS) between November 19, 2020 and November 12, 2021, inclusive (the “Class Period”), of the important April 8, 2022 lead plaintiff deadline. SO WHAT: If you purchased Telos […]

Read More

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TaskUs, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – TASK

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TaskUs, Inc. (NASDAQ: TASK) between June 11, 2021 and January 19, 2022, inclusive (the “Class Period”), of the important April 25, 2022 lead plaintiff deadline. SO WHAT: If you purchased TaskUs […]

Read More